Overview
- XRHealth has acquired PursueCare, a virtual healthcare provider specializing in addiction treatment and co-occurring mental health conditions.
- The acquisition includes PursueCare’s multidisciplinary telehealth services and two FDA-authorized prescription digital therapeutics, RESET and RESET-O.
- The combined platform will offer access to addiction specialists, therapists, psychiatrists, counselors, and case managers through mobile-based and virtual care.
- The deal expands XRHealth’s connected healthcare ecosystem across smartphones, wearables, AR/VR devices, and immersive virtual support groups.
The News
XRHealth has acquired PursueCare to expand its virtual healthcare platform into addiction treatment and behavioral health. PursueCare provides personalized treatment for alcohol, opioid, cannabis, kratom, and 7-OH use disorders, alongside co-occurring mental health conditions.
The acquisition brings together PursueCare’s clinical services and XRHealth’s technology-driven care model. Patients will gain access to licensed clinicians, therapists, psychiatrists, counselors, and case managers through secure telehealth and mobile-based services.
PursueCare’s treatment model combines medication-based care, behavioral therapies, cognitive behavioral therapy (CBT), psychiatric support, and case management. Its services also address practical barriers to recovery, including transitions from hospitals and correctional facilities and access to community resources.
The deal also includes two FDA-authorized prescription digital therapeutics: RESET, indicated to support abstinence and treatment retention in adults with substance use disorder, and RESET-O, designed to improve outpatient treatment retention in adults with opioid use disorder receiving buprenorphine and contingency management. Both deliver evidence-based CBT through smartphones, extending recovery support between clinical appointments while allowing clinicians to monitor patient engagement and reported progress.
PursueCare will also become part of XRHealth’s immersive care ecosystem, which includes VR-based support groups where patients can participate through avatars for greater privacy and anonymity.
Industry Perspective
The acquisition highlights growing interest in combining virtual clinical services with digital therapeutics to address gaps in behavioral healthcare. Addiction treatment often requires continuous support beyond scheduled appointments, making remote monitoring, mobile-based interventions, and accessible clinical teams valuable additions to traditional care models.
Strategic Impact
For XRHealth, the acquisition expands its portfolio beyond immersive therapeutic technologies into specialized addiction and behavioral healthcare. PursueCare gains access to a broader ecosystem of digital devices and VR-based engagement tools, creating opportunities to extend treatment and peer support beyond conventional telehealth appointments. The combination could strengthen XRHealth’s position in connected virtual care while addressing an underserved patient population.
Source: PRnewswire
